Hem › Multipelt myelom › Virginia › Arlington
Kliniska studier för Multipelt myelom i Arlington, VA
9 studier för Multipelt myelom söker deltagare vid platser i och runt Arlington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
RekryterarFas 2/3
- Virginia Cancer Specialists - Fairfax /ID# 278716, Fairfax · 11 mi bort
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekryterarFas 2
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
RekryterarFas 1/2
- Research Site, Fairfax · 11 mi bort
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekryterarFas 3
- Research Site, Fairfax · 11 mi bort
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11 mi bort
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekryterarFas 3
- GSK Investigational Site, Fairfax · 11 mi bort
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
RekryterarFas 2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
RekryterarFas 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi bort
Multipelt myelom-studier i andra städer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andra studier i Arlington
- Icke-småcellig lungcancer104 studier
- Metastaserande cancer53 studier
- Kolorektal cancer52 studier
- Cancer (alla typer)48 studier
- Bröstcancer46 studier
- Äggstockscancer46 studier
- Lungcancer41 studier
- Endometriecancer39 studier
- Bukspottkörtelcancer33 studier
- Plattenepitelcancer i huvud och hals26 studier
- Småcellig lungcancer23 studier
- Triplenegativ bröstcancer20 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.